Ivelina Dobreva

UCL Queen Square Institute Of Neurology
London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Data-driven trajectories of atrophy explain clinical heterogeneity across Lewy body diseases.

Data-driven trajectories of atrophy explain clinical heterogeneity across Lewy body diseases.

Journal: medRxiv : the preprint server for health sciences

Published: July 17, 2026

Gray Matter Microstructure Measured Using Diffusion Imaging as a Biomarker of Severity in Lewy Body Diseases.

Gray Matter Microstructure Measured Using Diffusion Imaging as a Biomarker of Severity in Lewy Body Diseases.

Journal: Movement disorders : official journal of the Movement Disorder Society

Published: February 26, 2026

Data-driven trajectories of atrophy explain clinical heterogeneity across Lewy body diseases.

Data-driven trajectories of atrophy explain clinical heterogeneity across Lewy body diseases.

Journal: EBioMedicine

Published: February 16, 2026

Diffusion tensor imaging analysis along the perivascular space suggests impaired glymphatic clearance in Lewy body dementia subtypes.

Diffusion tensor imaging analysis along the perivascular space suggests impaired glymphatic clearance in Lewy body dementia subtypes.

Journal: Alzheimer's research & therapy

Published: November 25, 2025

Evidence for divergent cortical organisation in Parkinson's disease and Lewy Body Dementia.

Evidence for divergent cortical organisation in Parkinson's disease and Lewy Body Dementia.

Journal: Nature communications

Published: July 09, 2025

Understanding barriers and facilitators to participation in Parkinson's research in Black communities in the UK.

Understanding barriers and facilitators to participation in Parkinson's research in Black communities in the UK.

Journal: Journal of Parkinson's disease

Published: June 20, 2025

Reply: Reconsidering white matter vulnerability and biomarker interpretation across Lewy body dementia subtypes.

Reply: Reconsidering white matter vulnerability and biomarker interpretation across Lewy body dementia subtypes.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association

Published: June 17, 2025

Quantitative susceptibility mapping reveals differences between subtypes of Lewy body dementia.

Quantitative susceptibility mapping reveals differences between subtypes of Lewy body dementia.

Journal: Brain : a journal of neurology

Published: February 03, 2025

Neuroimaging and plasma biomarker differences and commonalities in Lewy body dementia subtypes.

Neuroimaging and plasma biomarker differences and commonalities in Lewy body dementia subtypes.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association

Published: January 27, 2025

Impaired Glymphatic Clearance, Measured Using Diffusion Tensor Image Analysis Along the Perivascular Space (DTI-ALPS), is Linked to Poor Cognitive Outcomes in Parkinson's Disease.

Impaired Glymphatic Clearance, Measured Using Diffusion Tensor Image Analysis Along the Perivascular Space (DTI-ALPS), is Linked to Poor Cognitive Outcomes in Parkinson's Disease.

Journal: Movement disorders : official journal of the Movement Disorder Society

Published: January 16, 2025

Improving Conversations about Parkinson's Dementia.

Improving Conversations about Parkinson's Dementia.

Journal: Movement disorders clinical practice

Published: November 17, 2023

A neuroimaging measure to capture heterogeneous patterns of atrophy in Parkinson's disease and dementia with Lewy bodies.

A neuroimaging measure to capture heterogeneous patterns of atrophy in Parkinson's disease and dementia with Lewy bodies.

Journal: NeuroImage. Clinical

Published: November 09, 2023

Showing 1-12 of 13

Last Updated: 09/26/2026